Abstract
BackgroundTreatment of rheumatoid arthritis (RA) has been revolutionized by the introduction of tumor necrosis factor inhibitors (TNFi). Nonetheless a significant proportion of patients fails to respond (primary failure) or may...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
